TR199900138T2 - Osteoporozun tedavisi için indolin türevleri. - Google Patents

Osteoporozun tedavisi için indolin türevleri.

Info

Publication number
TR199900138T2
TR199900138T2 TR1999/00138T TR9900138T TR199900138T2 TR 199900138 T2 TR199900138 T2 TR 199900138T2 TR 1999/00138 T TR1999/00138 T TR 1999/00138T TR 9900138 T TR9900138 T TR 9900138T TR 199900138 T2 TR199900138 T2 TR 199900138T2
Authority
TR
Turkey
Prior art keywords
sub
alkyl
optionally substituted
group
compound
Prior art date
Application number
TR1999/00138T
Other languages
English (en)
Inventor
Farina Carlo
Gagliardi Stefania
Marguerite Marie Gerard Nadler Guy
Original Assignee
Smithkline Beecham S.P.A.
Smithkline Beecham Laboratoires Pharmaceutiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614367.2A external-priority patent/GB9614367D0/en
Priority claimed from GBGB9626697.8A external-priority patent/GB9626697D0/en
Priority claimed from GBGB9626700.0A external-priority patent/GB9626700D0/en
Application filed by Smithkline Beecham S.P.A., Smithkline Beecham Laboratoires Pharmaceutiques filed Critical Smithkline Beecham S.P.A.
Publication of TR199900138T2 publication Critical patent/TR199900138T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Ra'nin, hidrojen, alkil veya tercihe göre ikameli aril olan R5 grubunu temsil ettigi, ve Rb'nin, X'in, alkil grubunun ikameli veya ikamesiz olabildigi bir hidroksi veya bir alkoksi grubunu temsil ettigi veya X'in, R8 ve Rt'nin her birinin bagimsiz olarak hidrojen, alkil, ikameli alkil, tercihe göre ikameli alkenil, aril, arilalkil, heterosiklik grup veya bir heterosiklikalkil grubunu temsil ettikleri veya Ra ile Rt'nin, bagli olduklari nitrojen ile birlikte bir heteroksiklik grubunu olusturduklari bir formül (a) kismini temsil ettigi; R1' in bir alkil veya ikameli ya da ikamesiz bir aril grubunu temsil ettigi; ve R2,R3 ile R4'ün herbirinin bagimsiz olarak hidrojen, alkil, aril veya ikameli aril'i temsil ettikleri; R6 ve R7' nin herbirinin bagimsiz olarak hidrojen, hidroksi, amino, alkoksi, tercihe göre ikameli ariloksi, tercihe göre ikameli benziloksi, alkilamino dialkilamino, halo, triflorometil, triflorometoksi, nitro, alkil, karboksi, karbaloksi, karbamoyl, (DEVAMI VAR)
TR1999/00138T 1996-07-09 1997-07-03 Osteoporozun tedavisi için indolin türevleri. TR199900138T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9614367.2A GB9614367D0 (en) 1996-07-09 1996-07-09 Novel compounds
GBGB9626697.8A GB9626697D0 (en) 1996-12-23 1996-12-23 Novel compounds
GBGB9626700.0A GB9626700D0 (en) 1996-12-23 1996-12-23 Novel compounds

Publications (1)

Publication Number Publication Date
TR199900138T2 true TR199900138T2 (tr) 1999-04-21

Family

ID=27268385

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00138T TR199900138T2 (tr) 1996-07-09 1997-07-03 Osteoporozun tedavisi için indolin türevleri.

Country Status (21)

Country Link
US (2) US20020173659A1 (tr)
EP (1) EP0914321B1 (tr)
JP (1) JP2000514074A (tr)
KR (1) KR20000023646A (tr)
AT (1) ATE277037T1 (tr)
AU (1) AU3620597A (tr)
BR (1) BR9710230A (tr)
CA (1) CA2259598A1 (tr)
CZ (1) CZ3799A3 (tr)
DE (1) DE69730837T2 (tr)
ES (1) ES2229375T3 (tr)
ID (1) ID18181A (tr)
IL (1) IL127668A0 (tr)
MA (1) MA24349A1 (tr)
NO (1) NO990080D0 (tr)
PE (1) PE46699A1 (tr)
PL (1) PL330994A1 (tr)
TR (1) TR199900138T2 (tr)
TW (1) TW397684B (tr)
UY (2) UY24608A1 (tr)
WO (1) WO1998001443A1 (tr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0974584B1 (en) 1997-02-21 2003-01-15 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
HU226587B1 (en) * 1998-05-15 2009-04-28 Wyeth Corp Pharmaceutical composition containing 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
GB9914371D0 (en) 1999-06-18 1999-08-18 Smithkline Beecham Plc Novel compounds
SE9903610D0 (sv) * 1999-10-06 1999-10-06 Astra Ab Novel compounds II
SE9903611D0 (sv) * 1999-10-06 1999-10-06 Astra Ab Novel compounds III
SE9903760D0 (sv) * 1999-10-18 1999-10-18 Astra Ab New compounds
DE10022925A1 (de) * 2000-05-11 2001-11-15 Basf Ag Substituierte Indole als PARP-Inhibitoren
WO2002007721A2 (en) 2000-07-20 2002-01-31 Lauras As Use of cox-2 inhibitors for preventing immunodeficiency
MXPA03008143A (es) 2001-03-09 2005-08-16 Johnson & Johnson Compuestos heterociclicos.
JP2005510482A (ja) * 2001-10-16 2005-04-21 アストラゼネカ・アクチエボラーグ 線維筋痛症候群の治療方法
WO2004022060A2 (en) 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
JP4384052B2 (ja) * 2002-11-25 2009-12-16 エフ．ホフマン−ラ ロシュ アーゲー インドリル誘導体
US6916852B2 (en) * 2003-05-12 2005-07-12 University Of Tennessee Research Foundation Method for regulation of microvascular tone
ITMI20040875A1 (it) * 2004-04-30 2004-07-30 Ist Naz Stud Cura Dei Tumori Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali
EP1779848A1 (en) 2005-10-28 2007-05-02 Nikem Research S.R.L. V-ATPase inhibitors for the treatment of inflammatory and autoimmune diseases
EP1779849A1 (en) 2005-10-28 2007-05-02 Nikem Research S.R.L. V-ATPase inhibitors for the treatment of septic shock
WO2010144611A2 (en) * 2009-06-10 2010-12-16 3-V Biosciences, Inc. Antivirals that target transporters, carriers, and ion channels
WO2012045451A1 (en) 2010-10-05 2012-04-12 Ludwig-Maximilians-Universitaet Muenchen Novel therapeutic treatment of progranulin-dependent diseases
CA2877474A1 (en) * 2011-06-20 2012-12-27 Myrexis, Inc. Compounds and therapeutic uses thereof
US20230219881A1 (en) * 2022-01-11 2023-07-13 Compound Solutions Inc. Synthesis of Spermidine, Spermine, and Free Bases Thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2038925A1 (en) * 1990-03-26 1991-09-27 Takashi Sohda Indole derivatives, their production and use
WO1993001280A1 (en) * 1991-07-08 1993-01-21 Roland Baron Inhibition of proton pump in osteoclast cells
JPH07223945A (ja) * 1994-02-10 1995-08-22 Snow Brand Milk Prod Co Ltd 骨疾患治療剤
SK93297A3 (en) 1995-01-10 1998-02-04 Smithkline Beecham Spa Indole derivatives, method for their producing, pharmaceutical comosition containing the same, and their use

Also Published As

Publication number Publication date
EP0914321B1 (en) 2004-09-22
IL127668A0 (en) 1999-10-28
CA2259598A1 (en) 1998-01-15
CZ3799A3 (cs) 1999-08-11
UY24608A1 (es) 1997-12-19
ATE277037T1 (de) 2004-10-15
US6903117B2 (en) 2005-06-07
EP0914321A1 (en) 1999-05-12
ES2229375T3 (es) 2005-04-16
AU3620597A (en) 1998-02-02
NO990080L (no) 1999-01-08
US20040010012A1 (en) 2004-01-15
US20020173659A1 (en) 2002-11-21
BR9710230A (pt) 1999-08-10
MA24349A1 (fr) 1998-07-01
KR20000023646A (ko) 2000-04-25
UY24802A1 (es) 2001-03-16
PE46699A1 (es) 1999-06-12
WO1998001443A1 (en) 1998-01-15
JP2000514074A (ja) 2000-10-24
TW397684B (en) 2000-07-11
PL330994A1 (en) 1999-06-21
NO990080D0 (no) 1999-01-08
ID18181A (id) 1998-03-12
DE69730837D1 (de) 2004-10-28
DE69730837T2 (de) 2005-09-29

Similar Documents

Publication Publication Date Title
TR199900138T2 (tr) Osteoporozun tedavisi için indolin türevleri.
BG101769A (en) Indole derivatives useful in the treatment of osteoporosis
MX9804107A (es) Derivados de quinolina.
DK0958296T3 (da) Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
HUP0100615A2 (hu) Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
NZ505060A (en) 2-Aryl or heterocyclyl substituted indole derivatives useful for the treatment of osteoporosis
ES2010284A6 (es) Procedimiento para preparar derivados de tiourea.
AU2961697A (en) Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
ATE234818T1 (de) Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69330601T2 (de) Serotoninergische ergolin derivate
AU693241B2 (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
DE3460896D1 (en) 5-amino-1,2-dithiol-3-one derivatives, their preparation and medicinal compositions containing them
NZ275620A (en) 3-optionally substituted phenyl or naphthyl-1,2,4-triazole derivatives; pharmaceutical compositions
JO1720B1 (en) Heterocyclic derivatives